Coverart for item
The Resource A Treatise on Topical Corticosteroids in Dermatology : Use, Misuse and Abuse

A Treatise on Topical Corticosteroids in Dermatology : Use, Misuse and Abuse

Label
A Treatise on Topical Corticosteroids in Dermatology : Use, Misuse and Abuse
Title
A Treatise on Topical Corticosteroids in Dermatology
Title remainder
Use, Misuse and Abuse
Creator
Subject
Language
eng
Summary
This treatise aims to fill up the lacuna and to contribute significantly to the dissemination of knowledge about the indication/contraindication, mechanism of action, ethical use, side-effects and various other facets related to topical corticosteroid. Topical corticosteroids (TC) have greatly enhanced dermatologists' ability to effectively treat several difficult dermatoses. The available range of formulations and potencies allows them to flexibly treat all groups of patients, different phases of disease, and different anatomic sites. Improper/incomplete knowledge about topical corticosteroids' mechanism of action, indications, classifications, and contraindications has produced a rapid rise in the incidence of improper use of these drugs, which could potentially bring disrepute to this entire group of amazing drugs. Responsibility for disseminating proper knowledge regarding when, where, and how to use TC both to internists and patients primarily rests with dermatologists. In this regard, the benefits of rational and ethical use and the potential harm of overuse and misuse for nonmedical, especially cosmetic purposes, should be clearly conveyed before prescribing TC
Member of
Cataloging source
EBLCP
http://library.link/vocab/creatorName
Lahiri, Koushik
Dewey number
610
Index
no index present
LC call number
R1
Literary form
non fiction
Nature of contents
dictionaries
http://library.link/vocab/subjectName
  • Dermatologic agents
  • Adrenocortical hormones
  • Dermatologic Agents
Label
A Treatise on Topical Corticosteroids in Dermatology : Use, Misuse and Abuse
Instantiates
Publication
Note
4.2.8 Hand Eczema
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Foreword; Topical Corticosteroids: The Boon and the Bane; Preface; Acknowledgments; Contents; About the Editor; Biography; Contributors; 1: Evolution and Development of Topical Corticosteroids; 1.1 Introduction; 1.2 The Early Stages: A 'Planned Serendipity'?; 1.3 Early Developments: The Commercial Side; 1.4 The First Topical Use of Corticosteroid: The War-ƯRavaged World Got a Blessing!; 1.5 Fluorinated Agents: An Endeavour for More Potent and Better Activity; 1.6 Betamethasone: A Landmark in the Topical Therapy; 1.7 Further Progress in Topical Therapy: An Effort for Betterment!
  • 1.8 Development of the Assay Methods: Scientific Evaluation Was InevitableReferences; 2: Topical Corticosteroids: Pharmacology; 2.1 Structure-Activity Relationship; 2.2 Potency of Topical Corticosteroids: How to Determine; 2.3 Classification of Topical Corticosteroids; 2.4 Mechanism of Action; 2.5 Pharmacological Actions of Corticosteroids; 2.5.1 Anti-Inflammatory and Immuno-Suppressant Effects; 2.5.2 Vasoconstrictor Action; 2.5.3 Anti-Proliferative Action; 2.6 Therapeutic Indications; 2.7 Formulations; 2.8 Selection and Use of Topical Corticosteroids
  • 2.9 Adverse Drug Reactions (ADRs)2.10 Contraindications; 2.11 Topical Corticosteroids in Special Populations; 2.11.1 Pregnancy and Lactation; 2.11.2 Geriatric and Paediatric Patients; 2.12 Recent Advances; References; 3: Dermatological Indications and Usage of Topical Corticosteroid; 3.1 Introduction; 3.1.1 Structure; 3.1.2 Strength; 3.1.3 Absorption; 3.1.4 Safety in Pregnancy and Breastfeeding; 3.1.5 Vehicles and Preparation; 3.1.6 Combination; 3.1.7 Frequency of Administration and Duration of Treatment; 3.1.8 Occlusion; 3.1.9 Intralesional Administration; 3.1.10 Side Effect
  • 3.2 Indications3.2.1 Atopic Dermatitis; 3.2.2 Seborrhoeic Dermatitis (SD); 3.2.3 Contact Dermatitis (CD); 3.2.4 Photosensitive Eczema; 3.2.5 Lichen Simplex Chronicus (LSC); 3.2.6 Hand Eczema and Pityriasis Alba; 3.2.7 Peristomal Dermatoses; 3.2.8 Psoriasis; 3.2.9 TCS in Children with Psoriasis; 3.2.10 Lichen Planus (LP); 3.2.11 Alopecia Areata (AA); 3.2.12 Vitiligo; 3.2.13 Cutaneous Lupus Erythematosus (CLE); 3.2.14 Blistering Disorders; 3.2.15 Haemangiomas; 3.2.16 Intertrigo and Perianal Inflammation; 3.2.17 Peristomal Inflammation; 3.2.18 Phimosis/Labial Adhesion
  • 3.2.19 Lichen Sclerosus3.2.20 Keloid and Hypertrophic Scars; 3.2.21 Melasma; 3.2.22 Burns; 3.2.23 Chronic Idiopathic Urticaria and Urticaria Pigmentosa; 3.2.24 TCS as Pretreatment; 3.2.25 Granulomatous Diseases; 3.2.26 Sarcoidosis; 3.2.27 Nodulocystic Acne; 3.2.28 Mucocele; References; 4: An Evidence Based Approach of Use of Topical Corticosteroids in Dermatology; 4.1 Introduction; 4.2 Discussion and Evidences; 4.2.1 Eczema; 4.2.2 Vitiligo; 4.2.3 Psoriasis; 4.2.4 Lichen Planus; 4.2.5 Mycosis Fungoides; 4.2.6 Bullous Pemphigoid; 4.2.7 Cutaneous Sarcoidosis
Control code
SPR1001367626
Dimensions
unknown
Extent
1 online resource (333 pages)
Form of item
online
Isbn
9789811046087
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other control number
10.1007/978-981-10-4609-4
Specific material designation
remote
System control number
  • on1001367626
  • (OCoLC)1001367626
Label
A Treatise on Topical Corticosteroids in Dermatology : Use, Misuse and Abuse
Publication
Note
4.2.8 Hand Eczema
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Foreword; Topical Corticosteroids: The Boon and the Bane; Preface; Acknowledgments; Contents; About the Editor; Biography; Contributors; 1: Evolution and Development of Topical Corticosteroids; 1.1 Introduction; 1.2 The Early Stages: A 'Planned Serendipity'?; 1.3 Early Developments: The Commercial Side; 1.4 The First Topical Use of Corticosteroid: The War-ƯRavaged World Got a Blessing!; 1.5 Fluorinated Agents: An Endeavour for More Potent and Better Activity; 1.6 Betamethasone: A Landmark in the Topical Therapy; 1.7 Further Progress in Topical Therapy: An Effort for Betterment!
  • 1.8 Development of the Assay Methods: Scientific Evaluation Was InevitableReferences; 2: Topical Corticosteroids: Pharmacology; 2.1 Structure-Activity Relationship; 2.2 Potency of Topical Corticosteroids: How to Determine; 2.3 Classification of Topical Corticosteroids; 2.4 Mechanism of Action; 2.5 Pharmacological Actions of Corticosteroids; 2.5.1 Anti-Inflammatory and Immuno-Suppressant Effects; 2.5.2 Vasoconstrictor Action; 2.5.3 Anti-Proliferative Action; 2.6 Therapeutic Indications; 2.7 Formulations; 2.8 Selection and Use of Topical Corticosteroids
  • 2.9 Adverse Drug Reactions (ADRs)2.10 Contraindications; 2.11 Topical Corticosteroids in Special Populations; 2.11.1 Pregnancy and Lactation; 2.11.2 Geriatric and Paediatric Patients; 2.12 Recent Advances; References; 3: Dermatological Indications and Usage of Topical Corticosteroid; 3.1 Introduction; 3.1.1 Structure; 3.1.2 Strength; 3.1.3 Absorption; 3.1.4 Safety in Pregnancy and Breastfeeding; 3.1.5 Vehicles and Preparation; 3.1.6 Combination; 3.1.7 Frequency of Administration and Duration of Treatment; 3.1.8 Occlusion; 3.1.9 Intralesional Administration; 3.1.10 Side Effect
  • 3.2 Indications3.2.1 Atopic Dermatitis; 3.2.2 Seborrhoeic Dermatitis (SD); 3.2.3 Contact Dermatitis (CD); 3.2.4 Photosensitive Eczema; 3.2.5 Lichen Simplex Chronicus (LSC); 3.2.6 Hand Eczema and Pityriasis Alba; 3.2.7 Peristomal Dermatoses; 3.2.8 Psoriasis; 3.2.9 TCS in Children with Psoriasis; 3.2.10 Lichen Planus (LP); 3.2.11 Alopecia Areata (AA); 3.2.12 Vitiligo; 3.2.13 Cutaneous Lupus Erythematosus (CLE); 3.2.14 Blistering Disorders; 3.2.15 Haemangiomas; 3.2.16 Intertrigo and Perianal Inflammation; 3.2.17 Peristomal Inflammation; 3.2.18 Phimosis/Labial Adhesion
  • 3.2.19 Lichen Sclerosus3.2.20 Keloid and Hypertrophic Scars; 3.2.21 Melasma; 3.2.22 Burns; 3.2.23 Chronic Idiopathic Urticaria and Urticaria Pigmentosa; 3.2.24 TCS as Pretreatment; 3.2.25 Granulomatous Diseases; 3.2.26 Sarcoidosis; 3.2.27 Nodulocystic Acne; 3.2.28 Mucocele; References; 4: An Evidence Based Approach of Use of Topical Corticosteroids in Dermatology; 4.1 Introduction; 4.2 Discussion and Evidences; 4.2.1 Eczema; 4.2.2 Vitiligo; 4.2.3 Psoriasis; 4.2.4 Lichen Planus; 4.2.5 Mycosis Fungoides; 4.2.6 Bullous Pemphigoid; 4.2.7 Cutaneous Sarcoidosis
Control code
SPR1001367626
Dimensions
unknown
Extent
1 online resource (333 pages)
Form of item
online
Isbn
9789811046087
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other control number
10.1007/978-981-10-4609-4
Specific material designation
remote
System control number
  • on1001367626
  • (OCoLC)1001367626

Library Locations

Processing Feedback ...